Pharmaceutical Research

, Volume 25, Issue 2, pp 435–440 | Cite as

Novel Beads Made of Alpha-cyclodextrin and Oil for Topical Delivery of a Lipophilic Drug

  • Laury Trichard
  • M. Begoña Delgado-Charro
  • Richard H. Guy
  • Elias Fattal
  • Amélie Bochot
Short Communication



To investigate the potential of a novel lipid carrier, comprising beads of alpha-cyclodextrin and soybean oil, for topical drug delivery. Adapalene was chosen as a model drug to explore the ability of the beads to encapsulate and release a highly lipophilic compound.

Materials and Methods

Adapalene-loaded beads were prepared and characterised. Skin tolerance to unloaded beads was tested on human volunteers, while drug release and delivery into stratum corneum, was evaluated in pig skin ex vivo.


The preparation and physical characteristics of the beads were not dependent on whether adapalene had been previously dissolved or dispersed in soybean oil. Drug encapsulation efficiency was high (>96%) and drug loading on the order of a therapeutic level could be achieved in freeze-dried beads prepared from an oily dispersion of adapalene. After application to human skin, unloaded beads induced no adverse reaction and were better tolerated than an alcoholic gel. Tape-stripping the stratum corneum from treated pig skin showed that adapalene release and penetration from the beads was comparable to that from gel and cream formulations available on the market.


These novel beads may offer a well-tolerated and efficient system for the encapsulation and topical delivery of lipophilic drugs.

Key words

adapalene bead cyclodextrin lipid carrier topical formulation 


  1. 1.
    A. Kogan, and N. Garti. Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci. 123–126:369–385 (2006).PubMedCrossRefGoogle Scholar
  2. 2.
    D. B. Yarosh. Liposomes in investigative dermatology. Photodermatol. Photoimmunol. Photomed. 17:203–212 (2001).PubMedCrossRefGoogle Scholar
  3. 3.
    R. H. Muller, M. Radtke, and S. A. Wissing. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54:S131–S155 (2002).PubMedCrossRefGoogle Scholar
  4. 4.
    A. Bochot, L. Trichard, G. Le Bas, H. Alphandary, J.-L. Grossiord, D. Duchêne and E. Fattal. α-cyclodextrin/oil beads: an innovative self-assembling system. Int. J. Pharm. 339:121–129 (2007).Google Scholar
  5. 5.
    I. Alberti, Y. N. Kalia, A. Naik, J. Bonny, and R. H. Guy. Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo. Int. J. Pharm. 219:11–19 (2001).PubMedCrossRefGoogle Scholar
  6. 6.
    N. Sekkat, Y. N. Kalia, and R. H. Guy. Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J. Pharm. Sci. 91:2376–2381 (2002).PubMedCrossRefGoogle Scholar
  7. 7.
    R. L. Anderson, and M. Cassidy. Variations in physical dimensions and chemical composition of human stratum corneum. J. Invest. Dermatol. 61:30–32 (1973).PubMedCrossRefGoogle Scholar
  8. 8.
    J. Allec, A. Chatelus, and N. Wagner. Skin distribution and pharmaceutical aspects of adapalene gel. J. Am. Acad. Dermatol. 36:S119–125 (1997).PubMedCrossRefGoogle Scholar
  9. 9.
    A. C. Williams, and B. W. Barry. Penetration enhancers. Adv. Drug Deliv. Rev. 56:603–618 (2004).PubMedCrossRefGoogle Scholar
  10. 10.
    K. Uekama, T. Irie, M. Sunada, M. Otagiri, Y. Arimatsu, and S. Nomura. Alleviation of prochlorperazine-induced primari irritation of skin by cyclodextrin complexation. Chem. Pharm. Bull. 30:3860–3862 (1982).PubMedGoogle Scholar
  11. 11.
    D. Duchêne, D. Wouessidjewe, and M. C. Poelman. Dermal uses of cyclodextrins and derivatives. In D. Duchêne (ed.), New Trends in Cyclodextrins and Derivatives, Edition de Santé, Paris, 1991, pp. 449–480.Google Scholar
  12. 12.
    G. Piel, S. Moutard, E. Uhoda, F. Pilard, G. E. Piérard, B. Perly, L. Delattre, and B. Evrard. Skin compatibility of cyclodextrins and their derivatives: a comparative assessment using a corneoxenometry bioassay. Eur. J. Pharm. Biopharm. 57:479–482 (2004).PubMedCrossRefGoogle Scholar
  13. 13.
    A. Rolland, N. Wagner, A. Chatelus, B. Shroot, and H. Shaefer. Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharm. Res. 10:1738–1744 (1993).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Laury Trichard
    • 1
    • 2
  • M. Begoña Delgado-Charro
    • 2
  • Richard H. Guy
    • 2
  • Elias Fattal
    • 1
  • Amélie Bochot
    • 1
  1. 1.Univ Paris-Sud, CNRS UMR 8612Physico-chimie – Pharmacotechnie – Biopharmacie, Faculté de PharmacieChâtenay-MalabryFrance
  2. 2.Department of Pharmacy and PharmacologyUniversity of BathBathUK

Personalised recommendations